Global expertise combined with in-depth experience and knowledge in Central and Eastern Europe.
Extensive PI/site network and unparalleled access to patient databases and key opinion leaders.
Unrivalled record for patient recruitment – our team has met or reduced enrollment timelines in 95% of trials conducted over our sixteen year history.
Responsible recruitment is supported by our “No Patients-No Payments” initiative – a unique risk-sharing program.
Optimized start-up timelines in our regions e.g. we achieve regulatory approvals in the Republic of Georgia, within two months of project signing (In Russia, 4 months, and in Ukraine, less than 5 months).
Cromos Pharma is looking forward to taking part in the upcoming DIA Europe conference (15 – 19 March 2021). A highly collaborative event, it’s a great chance to meet with future partners and hear from innovators across the entire life sciences spectrum.
Cromos Pharma is delighted to be participating in MAGI’s Clinical Research vConference (2-5 & 9-12 November). Our CEO Vlad Bogin, MD, FACP will be giving a presentation on the timely topic of Crisis Management (2 November, 2:30 PM-3:30 PM).